Skip to main content

Advertisement

SpringerLink
Log in

Intraocular bevacizumab for macular edema due to CRVO. A multifocal-ERG and OCT study

  • Original Research Article
  • Published:
Documenta Ophthalmologica Aims and scope Submit manuscript

Abstract

Purpose To evaluate by multifocal electroretinography (MFERG) and optical coherence tomography (OCT) the effectiveness of intravitreal use of bevacizumab (Avastin) in the treatment of macular edema due to central retinal vein occlusion (CRVO). Methods A total of 10 eyes of 10 patients (six males and four females) with macular edema due to CRVO were studied before and after intravitreal use of bevacizumab with MFERG and OCT. The post treatment follow-up was 3 months. Examination included measurement of best-corrected visual acuity (BCVA) for distance, measurement of intraocular pressure (IOP), fluorescein angiography, foveal-retinal thickness measurement by OCT, and MFERG recordings before treatment and 1 and 3 months after treatment. Results Before treatment, OCT shows an increase of the retinal thickness of the fovea. About 1 and 3 months after treatment the foveal thickness decreased to a significant level. The electrical responses in the fovea and parafovea of the MFERG recording depicted a significant improvement at 1 and 3 months after the injection. No patient manifested IOP increase. Conclusion The intravitreal use of bevacizumab may provide anatomical and functional amelioration of the macula in patients with macular edema due to CRVO. However, further study is needed in order to assess the treatment’s long-term efficacy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. The Central Vein Occlusion Study Group (1997) Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 115:486–491

    Google Scholar 

  2. The Central Vein Occlusion Study Group (1995) Evaluation of grid laser pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology 102:1425–1433

    Google Scholar 

  3. Noma H, Minamoto A, Funatsu H et al (2006) Intravitreal levels of endothelial growth factor and interleukin-6 are connected with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 244:309–315

    Article  PubMed  CAS  Google Scholar 

  4. Spandau UH, Ihlorf AK, Jost BJ (2006) Intravitreal bevacizumab treatment of macular oedema due to central retinal vein occlusion. Acta Ophthalmol Scand 84:555–556

    Article  PubMed  Google Scholar 

  5. Iturralde D, Spaide RF, Meyerle CB et al (2006) Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 26:279–284

    Article  PubMed  Google Scholar 

  6. Costa RA, Jorge R, Calluci D, Melo L, Cardilllo J, Scott IU (2007) Intravitreal bevacizumab (Avastin) for central and hemicentral retinal vein occlusions: IBeVO study. Retina 27:141–149

    Article  PubMed  Google Scholar 

  7. Spandau U, Wickenhauser A, Rench F, Jonas J (2007) Intravitreal bevacizumab for branch retinal vein occlusion. Acta Ophthalmol Scand 85:118

    Article  PubMed  Google Scholar 

  8. Sutter E, Tran D (1992) The field topography of ERG components in man-I. The photopic luminance response. Vision Res 32:433–446

    Article  PubMed  CAS  Google Scholar 

  9. Hood D (2000) Assessing retinal function with the multifocal technique. Prog Retin Eye Res 19:607–646

    Article  PubMed  CAS  Google Scholar 

  10. Marmor MF, Hood DC, Keating D, Kondo M, Seeliger MW, Miyake Y (2003) International Society for Clinical Electrophysiology of Vision. Guidelines for basic multifocal electroretinography (mfERG). Doc Ophthalmol 106(3):338

    Article  Google Scholar 

  11. Rosenfeld PG, Fung AE, Pulliafito CA (2005a) Optical coherence tomography findings after intravitreal injection of bevacizumab (Avastin) from macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 36:336–339

    PubMed  Google Scholar 

  12. Rosenfeld PG, Moshfeghi AA, Puliafito CA (2005b) Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36:331–335

    PubMed  Google Scholar 

  13. Ip M, Kahama A, Altaweel M (2003) Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study. Semin Ophthalmol 18:67–73

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, University of Athens, 144, Kountouriotou Str, 185 35, Piraeus, Athens, Greece

    Marilita M. Moschos & Michael Moschos

Authors
  1. Marilita M. Moschos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Moschos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marilita M. Moschos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moschos, M.M., Moschos, M. Intraocular bevacizumab for macular edema due to CRVO. A multifocal-ERG and OCT study. Doc Ophthalmol 116, 147–152 (2008). https://doi.org/10.1007/s10633-007-9110-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10633-007-9110-9

Keywords

Search

Navigation